Ovitrelle

choriogonadotropin alfa · Merck Europe B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ovitrelle, covering 2025-05-23 to 2025-05-23. Get the full timeline:

Most recent: EMA Authorised: Ovitrelle (choriogonadotropin alfa) — Merck Europe B.V.